Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.63
WST's Cash to Debt is ranked higher than
66% of the 315 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.11 vs. WST: 0.63 )
WST' s 10-Year Cash to Debt Range
Min: 0.08   Max: 0.82
Current: 0.63

0.08
0.82
Equity to Asset 0.57
WST's Equity to Asset is ranked higher than
69% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. WST: 0.57 )
WST' s 10-Year Equity to Asset Range
Min: 0.35   Max: 0.58
Current: 0.57

0.35
0.58
Interest Coverage 9.55
WST's Interest Coverage is ranked higher than
62% of the 212 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.30 vs. WST: 9.55 )
WST' s 10-Year Interest Coverage Range
Min: 3.33   Max: 14.27
Current: 9.55

3.33
14.27
F-Score: 7
Z-Score: 4.93
M-Score: -2.64
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 12.14
WST's Operating margin (%) is ranked higher than
80% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.14 vs. WST: 12.14 )
WST' s 10-Year Operating margin (%) Range
Min: 8.21   Max: 14.89
Current: 12.14

8.21
14.89
Net-margin (%) 8.22
WST's Net-margin (%) is ranked higher than
79% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.12 vs. WST: 8.22 )
WST' s 10-Year Net-margin (%) Range
Min: -1.33   Max: 9.81
Current: 8.22

-1.33
9.81
ROE (%) 12.98
WST's ROE (%) is ranked higher than
86% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.62 vs. WST: 12.98 )
WST' s 10-Year ROE (%) Range
Min: -2.73   Max: 17.79
Current: 12.98

-2.73
17.79
ROA (%) 6.88
WST's ROA (%) is ranked higher than
82% of the 316 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.40 vs. WST: 6.88 )
WST' s 10-Year ROA (%) Range
Min: -0.98   Max: 9.3
Current: 6.88

-0.98
9.3
ROC (Joel Greenblatt) (%) 18.79
WST's ROC (Joel Greenblatt) (%) is ranked higher than
77% of the 315 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.59 vs. WST: 18.79 )
WST' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 12.66   Max: 31.33
Current: 18.79

12.66
31.33
Revenue Growth (%) 8.40
WST's Revenue Growth (%) is ranked higher than
80% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.10 vs. WST: 8.40 )
WST' s 10-Year Revenue Growth (%) Range
Min: -2.9   Max: 17.8
Current: 8.4

-2.9
17.8
EBITDA Growth (%) 15.90
WST's EBITDA Growth (%) is ranked higher than
85% of the 240 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.10 vs. WST: 15.90 )
WST' s 10-Year EBITDA Growth (%) Range
Min: -9.4   Max: 20.2
Current: 15.9

-9.4
20.2
EPS Growth (%) 20.80
WST's EPS Growth (%) is ranked higher than
86% of the 244 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. WST: 20.80 )
WST' s 10-Year EPS Growth (%) Range
Min: -38.5   Max: 57.4
Current: 20.8

-38.5
57.4
» WST's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

WST Guru Trades in Q3 2013

RS Investment Management 939,832 sh (+189.93%)
Ron Baron 1,505,930 sh (+132.5%)
Jim Simons 675,900 sh (+45.42%)
Chuck Royce 20,800 sh (+42.47%)
Ken Fisher 1,275,398 sh (-3.3%)
Ruane Cunniff 1,080,813 sh (-3.69%)
Paul Tudor Jones 7,300 sh (-20.65%)
Steven Cohen 9,364 sh (-76.6%)
» More
Q4 2013

WST Guru Trades in Q4 2013

Joel Greenblatt 5,991 sh (New)
Jim Simons 920,000 sh (+36.11%)
Ron Baron 1,823,538 sh (+21.09%)
RS Investment Management 940,972 sh (+0.12%)
Chuck Royce Sold Out
Steven Cohen Sold Out
Ruane Cunniff 1,068,129 sh (-1.17%)
Ken Fisher 1,253,678 sh (-1.7%)
Paul Tudor Jones 7,000 sh (-4.11%)
» More
Q1 2014

WST Guru Trades in Q1 2014

Steven Cohen 15,920 sh (New)
Paul Tudor Jones 12,717 sh (+81.67%)
Jim Simons 1,419,800 sh (+54.33%)
Ron Baron 1,820,884 sh (-0.15%)
Ruane Cunniff 1,061,403 sh (-0.63%)
Ken Fisher 1,229,033 sh (-1.97%)
RS Investment Management 876,759 sh (-6.82%)
Joel Greenblatt 5,132 sh (-14.34%)
» More
Q2 2014

WST Guru Trades in Q2 2014

Paul Tudor Jones 26,710 sh (+110.03%)
RS Investment Management 1,387,516 sh (+58.26%)
Jim Simons 1,607,100 sh (+13.19%)
Ken Fisher 1,306,281 sh (+6.29%)
Joel Greenblatt Sold Out
Ruane Cunniff 1,056,701 sh (-0.44%)
Ron Baron 1,797,386 sh (-1.29%)
» More
» Details

Insider Trades

Latest Guru Trades with WST

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-06-30 Sold Out $41.28 - $45.46 $ 47.3110%0
Ron Baron 2013-12-31 Add 21.09%0.06%$39.88 - $50.08 $ 47.311%1823538
Joel Greenblatt 2013-12-31 New Buy0.01%$39.88 - $50.08 $ 47.311%5991
Ron Baron 2013-09-30 Add 132.5%0.16%$35.59 - $41.045 $ 47.3124%1505930
Ron Baron 2013-06-30 New Buy0.12%$30.95 - $35.14 $ 47.3144%323854
Joel Greenblatt 2012-12-31 Sold Out 0.14%$25.53 - $27.87 $ 47.3176%0
Ken Fisher 2012-12-31 Add 128.19%0.06%$25.53 - $27.87 $ 47.3176%634322
Joel Greenblatt 2012-09-30 Add 54.51%0.05%$23.57 - $26.73 $ 47.3190%38873
Ken Fisher 2012-09-30 Add 121.94%0.02%$23.57 - $26.73 $ 47.3190%277975
Joel Greenblatt 2012-06-30 New Buy0.09%$19.75 - $25.12 $ 47.31109%25159
Joel Greenblatt 2012-03-31 Sold Out 0.07%$18.9 - $21.4 $ 47.31146%0
Ruane Cunniff 2011-12-31 Add 134.01%0.12%$17.8 - $20.57 $ 47.31150%637162
Joel Greenblatt 2011-12-31 New Buy0.07%$17.8 - $20.57 $ 47.31150%14667
Ruane Cunniff 2011-09-30 Add 286.3%0.08%$18.46 - $23.23 $ 47.31128%272285
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 29.70
WST's P/E(ttm) is ranked higher than
81% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 35.10 vs. WST: 29.70 )
WST' s 10-Year P/E(ttm) Range
Min: 12.43   Max: 40.3
Current: 29.7

12.43
40.3
P/B 3.44
WST's P/B is ranked higher than
70% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.94 vs. WST: 3.44 )
WST' s 10-Year P/B Range
Min: 1.74   Max: 4.16
Current: 3.44

1.74
4.16
P/S 2.44
WST's P/S is ranked higher than
76% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.99 vs. WST: 2.44 )
WST' s 10-Year P/S Range
Min: 1   Max: 2.62
Current: 2.44

1
2.62
PFCF 50.87
WST's PFCF is ranked higher than
80% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 119.29 vs. WST: 50.87 )
WST' s 10-Year PFCF Range
Min: 18.37   Max: 349.33
Current: 50.87

18.37
349.33
EV-to-EBIT 20.30
WST's EV-to-EBIT is ranked higher than
82% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.34 vs. WST: 20.30 )
WST' s 10-Year EV-to-EBIT Range
Min: 7.2   Max: 23.8
Current: 20.3

7.2
23.8
PEG 2.64
WST's PEG is ranked higher than
90% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. WST: 2.64 )
WST' s 10-Year PEG Range
Min: 1.05   Max: 25.49
Current: 2.64

1.05
25.49
Shiller P/E 37.92
WST's Shiller P/E is ranked higher than
84% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 224.21 vs. WST: 37.92 )
WST' s 10-Year Shiller P/E Range
Min: 16.04   Max: 61.11
Current: 37.92

16.04
61.11
Current Ratio 3.10
WST's Current Ratio is ranked higher than
78% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.78 vs. WST: 3.10 )
WST' s 10-Year Current Ratio Range
Min: 1.45   Max: 3.1
Current: 3.1

1.45
3.1
Quick Ratio 2.25
WST's Quick Ratio is ranked higher than
78% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.82 vs. WST: 2.25 )
WST' s 10-Year Quick Ratio Range
Min: 1.09   Max: 2.28
Current: 2.25

1.09
2.28

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.87
WST's Dividend Yield is ranked lower than
64% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. WST: 0.87 )
WST' s 10-Year Dividend Yield Range
Min: 0.76   Max: 2.45
Current: 0.87

0.76
2.45
Dividend Payout 0.25
WST's Dividend Payout is ranked higher than
87% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. WST: 0.25 )
WST' s 10-Year Dividend Payout Range
Min: 0.13   Max: 2.9
Current: 0.25

0.13
2.9
Dividend growth (3y) 5.80
WST's Dividend growth (3y) is ranked higher than
76% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.70 vs. WST: 5.80 )
WST' s 10-Year Dividend growth (3y) Range
Min: 5.2   Max: 8.2
Current: 5.8

5.2
8.2
Yield on cost (5-Year) 1.20
WST's Yield on cost (5-Year) is ranked lower than
58% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. WST: 1.20 )
WST' s 10-Year Yield on cost (5-Year) Range
Min: 1.02   Max: 3.28
Current: 1.2

1.02
3.28
Share Buyback Rate 0.90
WST's Share Buyback Rate is ranked higher than
91% of the 244 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. WST: 0.90 )
WST' s 10-Year Share Buyback Rate Range
Min: 4.6   Max: -5.5
Current: 0.9

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 4.12
WST's Price/Tangible Book is ranked higher than
77% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.47 vs. WST: 4.12 )
WST' s 10-Year Price/Tangible Book Range
Min: 1.73   Max: 6.81
Current: 4.12

1.73
6.81
Price/DCF (Projected) 2.78
WST's Price/DCF (Projected) is ranked higher than
78% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.65 vs. WST: 2.78 )
WST' s 10-Year Price/DCF (Projected) Range
Min: 0.97   Max: 3.18
Current: 2.78

0.97
3.18
Price/Median PS Value 1.71
WST's Price/Median PS Value is ranked higher than
61% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. WST: 1.71 )
WST' s 10-Year Price/Median PS Value Range
Min: 0.48   Max: 1.79
Current: 1.71

0.48
1.79
Price/Peter Lynch Fair Value 1.92
WST's Price/Peter Lynch Fair Value is ranked higher than
93% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. WST: 1.92 )
WST' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.72   Max: 76.88
Current: 1.92

0.72
76.88
Price/Graham Number 2.31
WST's Price/Graham Number is ranked higher than
86% of the 327 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.05 vs. WST: 2.31 )
WST' s 10-Year Price/Graham Number Range
Min: 0.93   Max: 3.69
Current: 2.31

0.93
3.69
Earnings Yield (Greenblatt) 4.90
WST's Earnings Yield (Greenblatt) is ranked higher than
81% of the 316 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.30 vs. WST: 4.90 )
WST' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.2   Max: 13.8
Current: 4.9

4.2
13.8
Forward Rate of Return (Yacktman) 16.58
WST's Forward Rate of Return (Yacktman) is ranked higher than
91% of the 274 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. WST: 16.58 )
WST' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -5.1   Max: 18.1
Current: 16.58

-5.1
18.1

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:BAX, COV, TMO, COO, ISRG » details
Traded in other countries:WPS.Germany
West Pharmaceutical Services, Inc. was incorporated under the laws of the Commonwealth of Pennsylvania on July 27, 1923. It is a manufacturer of components and systems for injectable drug delivery and plastic packaging and delivery system components for the healthcare and consumer products industries. Majority of its business is conducted in healthcare markets. Its reportable segments are Packaging Systems and Delivery Systems. Packaging Systems develops, manufactures and sells primary packaging components and systems for injectable drug delivery, including stoppers and seals for vials, closures and other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Delivery Systems develops, manufactures and sells safety and administration systems, multi-component systems for drug administration, and a variety of custom contract-manufacturing solutions targeted to the healthcare and consumer-products industries. In addition, Delivery Systems is responsible for the continued development and commercialization of the Company's line of proprietary, multi-component systems for injectable drug administration and other healthcare applications. Packaging Systems has three operating segments: the Americas, Europe and Asia Pacific. The Company competes with several companies across its major product lines. Competition is based mainly on product design and performance, although total cost is becoming increasingly important as pharmaceutical companies continue with aggressive cost control programs across their entire operations. The design, development, manufacturing, marketing and labeling of certain of the Company's products and its customers' products that incorporate its products are subject to regulation by governmental authorities in the United States, Europe and other countries, including the FDA and the European Medicines Agency.
» More Articles for WST

Headlines

Articles On GuruFocus.com
West to Host Third Quarter 2014 Conference Call Oct 23 2014 
Is Cooper Companies' Upward Trend Likely to Go On? Mar 25 2014 
Illumina Inc: How Long Can a Miracle Go On? Feb 07 2014 
Buy ResMed and Sleep Tight (Like Jim Simons) Feb 02 2014 
The Best Dividends on April 16, 2012 Apr 13 2012 
Final Dividend Contenders - Part XII Jun 07 2011 
West Pharmaceutical Services Inc. Reports Operating Results (10-K) Feb 28 2011 
West Pharmaceutical Services Inc. (WST) COO & President Steven A Ellers sells 10,000 Shares Feb 24 2010 
West Pharmaceutical Services Inc. Reports Operating Results (10-Q) Nov 04 2009 
West Pharmaceutical Services Inc. (WST) COO & President Steven A Ellers sells 10,000 Shares Sep 01 2009 

More From Our Partners
The Week Ahead In Earnings Reports: Pharmaceuticals Oct 25 2014 - SEEKINGALPHA

More From Other Websites
West to Host Third Quarter 2014 Conference Call Oct 23 2014
West to Host Third Quarter 2014 Conference Call Oct 23 2014
West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark Oct 21 2014
West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark Oct 21 2014
West Pharmaceutical Services Warns On FY14, CEO To Retire Oct 15 2014
West Pharmaceutical CEO to retire next year Oct 15 2014
West Pharmaceutical CEO to retire next year Oct 15 2014
WEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Oct 15 2014
West Pharmaceutical Services Announces CEO Retirement and Succession Plan Oct 15 2014
West Pharmaceutical Services Announces CEO Retirement and Succession Plan Oct 15 2014
WEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements... Oct 07 2014
West Names New President of Pharmaceutical Packaging Systems Oct 07 2014
West Pharmaceutical Services and HealthPrize Technologies Join Forces on Connected Health Oct 06 2014
WEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements... Oct 02 2014
West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland Oct 02 2014
WEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements... Sep 09 2014
West to Present at Upcoming Investor Conferences Sep 02 2014
WEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Aug 15 2014
WEST PHARMACEUTICAL SERVICES INC Financials Aug 09 2014
WEST PHARMACEUTICAL SERVICES INC Files SEC form 8-K, Change in Directors or Principal Officers Aug 05 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK